New hires and promotions in the biopharma industry, including: Amag, Nanomab, Selecta.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Livanova, Personal Genome Diagnostics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Alphatec Holdings, Carmell Therapeutics, Electrocore, Eos Imaging, Erba Mannheim, Genalyte, Gilson, IBM, Institute for Systems Biology, Menarini-Silicon Biosystems, Merck, Nano-X Imaging, Novacyt Group, Ortho Clinical Diagnostics, O-Two Medical Technologies, Qiagen, Synaptive Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sightglass Vision.

New hires and promotions in the med-tech industry, including: Cytosorbents, Gendius.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Carmell, Carsgen, Cytodyn, Diffusion, Eiger, Green Valley, Halozyme, Janssen, Mateon, Neurocrine, Polyneuron, Takeda.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Arcturus, Ardigen, Armagen, Ashiya, Bioaegis, Biohaven, Clove, Crestone, Effector, Faron, Flexion, Generex, Harpoon, Innovation, JCR, Kamada, Kedrion, Merck, Orgenesis, Pharmacyte, Redhill, Tamir, Recursion, Santhera, Selvita, Tetra Bio-Pharma, Trilink, Valo Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Avadel, Axsome, CTI Biopharma, Harpoon, Hua, Italfarmaco, Myovant, Regeneron, Sanofi, Valo.

Biopharmas raising money in public or private financings, including: Actym, Actinium, ADC, Cyclacel, Cyclo, Erasca, Evofem, Lifesprout, Lyra, Rome, VBI.

New hires and promotions in the biopharma industry, including: ADC, Anika, Arcutis, Cerecor, Galecto, Mycovia, Nkarta, Saniona, Touchlight, Veritas, Xilio.